Controlling hypothalamic DNA methylation at the Pomc promoter does not regulate weight gain during the development of obesity
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0284286 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Taylor McFadden und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Animal Sciences, Virginia Polytechnic Institute and State University, Blacksburg, VA, United States of America. Hauptthemen laut MEDLINE: DNA Methylation, Pro-Opiomelanocortin. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, NIA NIH HHS, Commonwealth Health Research Board.
Abstract (Originalsprache)
Obesity is a complex medical condition that is linked to various health complications such as infertility, stroke, and osteoarthritis. Understanding the neurobiology of obesity is crucial for responding to the etiology of this disease. The hypothalamus coordinates many integral activities such as hormone regulation and feed intake and numerous studies have observed altered hypothalamic gene regulation in obesity models. Previously, it was reported that the promoter region of the satiety gene, Pomc , has increased DNA methylation in the hypothalamus following short-term exposure to a high fat diet, suggesting that epigenetic-mediated repression of hypothalamic Pomc might contribute to the development of obesity. However, due to technical limitations, this has never been directly tested. Here, we used the CRISPR-dCas9-TET1 and dCas9-DNMT3a systems to test the role of Pomc DNA methylation in the hypothalamus in abnormal weight gain following acute exposure to a high fat diet in male rats. We found that exposure to a high fat diet increases Pomc DNA methylation and reduces gene expression in the hypothalamus. Despite this, we found that CRISPR-dCas9-TET1-mediated demethylation of Pomc was not sufficient to prevent abnormal weight gain following exposure to a high fat diet. Furthermore, CRISPR-dCas9-DNMT3a-mediated methylation of Pomc did not alter weight gain following exposure to standard or high fat diets. Collectively, these results suggest that high fat diet induced changes in Pomc DNA methylation are a consequence of, but do not directly contribute to, abnormal weight gain during the development of obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Animal Sciences, Virginia Polytechnic Institute and State University, Blacksburg, VA, United States of America.
- School of Neuroscience, Virginia Polytechnic Institute and State University, Blacksburg, VA, United States of America.
ORCID-Profile: Timothy J Jarome
Förderung
- NIMH NIH HHS
- NIA NIH HHS
- Commonwealth Health Research Board
- National Institute of Mental Health
- National Institute on Aging
Zitieren
APA
McFadden, T., Gaito, N., Carucci, I., Fletchall, E., Farrell, K., & Jarome, T. J. (2023). Controlling hypothalamic DNA methylation at the Pomc promoter does not regulate weight gain during the development of obesity. PLOS ONE. https://doi.org/10.1371/journal.pone.0284286
Vancouver
McFadden T, Gaito N, Carucci I, Fletchall E, Farrell K, Jarome TJ. Controlling hypothalamic DNA methylation at the Pomc promoter does not regulate weight gain during the development of obesity. PLOS ONE. 2023. doi:10.1371/journal.pone.0284286
BibTeX
@article{McFadden2023,
author = {McFadden, Taylor and Gaito, Natasha and Carucci, Isabella and Fletchall, Everett and Farrell, Kayla and Jarome, Timothy J},
title = {Controlling hypothalamic DNA methylation at the Pomc promoter does not regulate weight gain during the development of obesity},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0284286}
}
EUVIMED